Total
0
Shares
MedAdvisor extends app to 600 pharmacies via Sigma deal
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Digital medication company MedAdvisor, has signed a two-year agreement with Sigma Healthcare, a pharmacy retail group
  • Sigma will support the use of MedAdvisor's mobile app by its pharmacy network of over 600 members
  • The virtual app connects with your local pharmacy to help you take medication safely, effectively and on-time
  • The company now has long term contracts with three of the four major pharmacy groups being Sigma, TerryWhite and Chemist Warehouse
  • MedAdvisor shares have gone up 18.4 per cent, with shares trading for 5.8 cents each

MedAdvisor, has signed a two-year agreement with Sigma Healthcare, a pharmacy retail group.

Sigma has a network of over 600 retail pharmacy franchise partners including Amcal, DDS, Guardian, PharmaSave, WholeLife and Chemist King pharmacy brands.

MedAdvisor already has over 400 Sigma group pharmacies already subscribed, however, this agreement will potentially add 200 more.

"Sigma has been a long-term shareholder and supporter of the business and we are pleased to formally document this agreement to help them better support their pharmacies, particularly as the market shifts with ePrescribing," MedAdvisor CEO Robert Read said.

Additionally, the company will provide custom branded versions of its mobile app for promotion and use by a number of Sigma brands.

The MedAdvisor app is a revolutionary software that puts a virtual pharmacist, "Pharmacist Phil" on your device. It connects with your local pharmacy to help you take medication safely, effectively and on-time.

MedAdvisor is available in almost 60 per cent of all Australia pharmacies which represents 12 million patients and over 70 per cent of prescription volume in Australia.

"We are pleased to be able to partner with MedAdvisor to further support electronic prescription readiness as we transition to an ePrescribing environment," Sigma Executive General Manager Jeffs Sells said.

"MedAdvisor continues to innovate and lead the market in both the patient app experience and pharmacy medication management software," Jeff added.

Under this agreement, the total revenue contribution from the Sigma network of brands will increase and is expected to exceed $1 million per year.

The company now has long term contracts with three of the four major pharmacy groups being Sigma, TerryWhite and Chemist Warehouse.

MedAdvisor shares have gone up 18.4 per cent, with shares trading for 5.8 cents each at market close.

MDR by the numbers
More From The Market Herald
Little Green Pharma (ASX:LGP) - Managing Director, Fleta Solomon - The Market Herald

" Little Green Pharma (ASX:LGP) pursues global expansion over June quarter

Little Green Pharma (LGP) celebrated backing from Gina Rhineheart and a major medicinal cannabis facility purchase over the June quarter but noted subdued

" Chimeric Therapeutics (ASX:CHM) obtains licence for solid tumour cell therapy

Chimeric Therapeutics (CHM) has obtained the exclusive licence to a novel treatment for solid tumours from the University of Pennsylvania.  
AnteoTech (ASX:ADO) - CEO, Derek Thomson - The Market Herald

" AnteoTech (ASX:ADO) strikes UK distribution deal for COVID-19 test tech

Surface chemistry company AnteoTech (ADO) has struck its first European distribution deal for its EuGeni rapid diagnostic test (RDT) technology.
Medlab Clinical (ASX:MDC) - CEO, Dr Sean Hall - The Market Herald

" Medlab Clinical (ASX:MDC) gets green light for US patent

Medlab Clinical (MDC) has been issued with a notice of allowance by the United States Patent Office (USPTO) regarding a patent for its